miR-100-5p modulates postprandial triglyceride response by targeting PCSK9
Cardiovascular Research · 22.10.2026
DOI: 10.1093/cvr/cvag247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 22.10.2026. Verfasst von Amandine Vanduyse und 16 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne University, Inserm, UMR_S1166, Research Institute of Cardiovascular Disease, Metabolism and Nutrition, Faculté de Médecine - Hôpital Pitié-S…. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Institut National de la Santé et de la Recherche Medicale, Sorbonne Université, French National Agency.
Abstract (Originalsprache)
Aims
Elevated postprandial hypertriglyceridaemia (PP-HTG) is a significant risk factor for the development of cardiovascular diseases; however, the mechanisms underlying its exaggerated rise remain poorly understood. MicroRNAs (miRs) are known to be implicated in the regulation of lipid metabolism, thus identifying them as potential key players. We presently investigated whether miRs may control postprandial triglyceride (PP-TG) response. Methods and results Postprandial changes in circulating miR expression as a function of the degree of postprandial TG response were evaluated in non-dyslipidaemic healthy subjects (n = 32). The impact of miR-100-5p on hepatic gene expression was evaluated in differentiated Caco2 and HepG2 cells by analysis of hepatic transcriptome (RNAseq), western blot, and ELISA. In vivo studies were conducted in C57BL/6J mice overexpressing mimic miR-100-5p. Postprandial variation in circ-miR-100-5p levels inversely correlates with PP-TG response. Cir-miR-100-5p was preferentially associated with triglyceride-rich lipoprotein (TGRL) particles of intestinal origin in subjects who exhibited a low PP-TG response. Differential analysis of transcriptome from HepG2 cells transfected with either mimic miR-100-5p or scrambled mimic miR as control allowed to identify PCSK9 as a down-regulated gene. Overexpression of miR-100-5p in HepG2 cells significantly decreased PCSK9 mRNA levels by 52% (P < 0.0001), cellular protein content by 28% (P < 0.0001) as well as PCSK9 secretion by 39% (P < 0.0001). In vivo systemic delivery of mimic miR-100-5p induced a two-fold reduction (P < 0.0001) on PP-TG in mice, such effect being abolished by blocking the circulating form of PCSK9 with alirocumab. Finally, we revealed a significant inverse relationship between circulating miR-100-5p expression levels and both PCSK9 levels and the magnitude of postprandial hypertriglyceridaemia.
Conclusion
Taken together, our observations reveal that miR-100-5p regulates postprandial hypertriglyceridaemia by targeting PCSK9, thus enhancing hepatic TGRL uptake. Our findings allow us to propose circ-miR-100-5p as a potential biomarker for early identification of subjects at high cardiovascular risk, before the appearance of classical clinical features of metabolic disorders. Postprandial clinical study: HDL-PP (NCT03109067).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sorbonne University, Inserm, UMR_S1166, Research Institute of Cardiovascular Disease, Metabolism and Nutrition, Faculté de Médecine - Hôpital Pitié-Salpêtrière, Paris, France.
- Hôpital Pitié-Salpêtrière, Assistance Publique Hôpitaux de Paris (AP-HP), Department of Biochemistry, Obesity and Dyslipidemia Genetics Unit, Paris, France.
- Centre d'Investigation Clinique Paris-Est CIC-1901, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France.
- Hôpital Pitié-Salpêtrière, AP-HP, Service de Biochimie Endocrinienne et Oncologique, Paris.
- Nantes Université, CHU Nantes, CNRS, INSERM, Institut du thorax, Nantes, France.
ORCID-Profile: Alexandre Motte, Sophie Galier, Olivier Bluteau, Clément Materne, Philippe Giral, Joe-Elie Salem, Jean-Marc Lacorte, Cedric Le May, Wilfried Le Goff, Philippe Lesnik, Maryse Guerin
Förderung
- Institut National de la Santé et de la Recherche Medicale
- Sorbonne Université
- French National Agency
- national program Investissements d’Avenir Grant
- Fondation de la Recherche Médicale
- Groupe Lipides et Nutrition
- European Joint Programme Initiative
- Healthy Diet for a healthy Healthy Life
Zitieren
APA
Vanduyse, A., Motte, A., Neves, C., Daclat, R., Galier, S., Bluteau, O., Materne, C., Frisdal, E., Durand, H., Giral, P., Salem, J. E., Lacorte, J. M., Le May, C., Le Goff, W., Lesnik, P., Guerin, M., & RESIST-PP Consortium (2026). miR-100-5p modulates postprandial triglyceride response by targeting PCSK9. Cardiovascular Research. https://doi.org/10.1093/cvr/cvag247
Vancouver
Vanduyse A, Motte A, Neves C, Daclat R, Galier S, Bluteau O, et al. miR-100-5p modulates postprandial triglyceride response by targeting PCSK9. Cardiovascular Research. 2026. doi:10.1093/cvr/cvag247
BibTeX
@article{Vanduyse2026,
author = {Vanduyse, Amandine and Motte, Alexandre and Neves, Carolina and Daclat, Rita and Galier, Sophie and Bluteau, Olivier and Materne, Clément and Frisdal, Eric and Durand, Hervé and Giral, Philippe and Salem, Joe-Elie and Lacorte, Jean-Marc and Le May, Cedric and Le Goff, Wilfried and Lesnik, Philippe and Guerin, Maryse and RESIST-PP Consortium, RESIST-PP Consortium},
title = {miR-100-5p modulates postprandial triglyceride response by targeting PCSK9},
journal = {Cardiovascular Research},
year = {2026},
doi = {10.1093/cvr/cvag247}
}
EUVIMED